Description

ISTAVEL D 5/50 MG (1X15)

Indications

ISTAVEL D 5/50 MG is primarily indicated for the management of allergic rhinitis and other allergic conditions. It is effective in alleviating symptoms such as sneezing, runny or itchy nose, and itchy or watery eyes. Additionally, this medication may be used to treat chronic urticaria (hives) and other skin allergies. The combination of its active ingredients provides a comprehensive approach to managing allergic symptoms, improving the quality of life for patients suffering from these conditions.

Mechanism of Action

ISTAVEL D contains two active ingredients: an antihistamine and a decongestant. The antihistamine component works by blocking the action of histamine, a substance in the body that causes allergic symptoms. By inhibiting histamine receptors, it reduces symptoms like itching, sneezing, and runny nose. The decongestant component acts by constricting blood vessels in the nasal passages, leading to reduced swelling and congestion. This dual action helps to provide relief from both nasal and ocular symptoms associated with allergies.

Pharmacological Properties

The pharmacological properties of ISTAVEL D are characterized by its active ingredients. The antihistamine component typically has a rapid onset of action, often within one hour, and its effects can last for up to 24 hours. This allows for once-daily dosing, enhancing patient compliance. The decongestant component provides immediate relief from nasal congestion, further improving breathing and comfort. The combination of these properties makes ISTAVEL D a valuable option in the management of allergic conditions.

Contraindications

ISTAVEL D is contraindicated in patients who have a known hypersensitivity to any of its components. It should not be used in individuals with severe hypertension or coronary artery disease, as the decongestant may exacerbate these conditions. Additionally, it is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing such treatment, due to the risk of hypertensive crisis. Caution is advised in patients with glaucoma, urinary retention, or prostatic hypertrophy.

Side Effects

Common side effects associated with ISTAVEL D include drowsiness, dry mouth, dizziness, and fatigue. Some patients may experience gastrointestinal disturbances such as nausea or constipation. Less common but more serious side effects may include increased heart rate, elevated blood pressure, or allergic reactions such as rash or difficulty breathing. It is essential for patients to report any unusual or severe side effects to their healthcare provider promptly.

Dosage and Administration

The recommended dosage of ISTAVEL D for adults and children over 12 years of age is one tablet (5/50 mg) taken once daily. It is advisable to take the medication with a full glass of water, and it can be taken with or without food. For children under 12 years, the use of ISTAVEL D should be determined by a healthcare provider based on individual needs and weight considerations. Patients should adhere to the prescribed dosage and not exceed the recommended amount to avoid potential adverse effects.

Interactions

ISTAVEL D may interact with other medications, which can alter its effectiveness or increase the risk of side effects. Caution should be exercised when used in conjunction with other central nervous system depressants, such as alcohol, sedatives, or tranquilizers, as these may enhance drowsiness. Additionally, the use of other antihistamines or decongestants should be avoided unless directed by a healthcare provider. Patients should inform their healthcare provider of all medications they are currently taking to prevent potential interactions.

Precautions

Prior to initiating treatment with ISTAVEL D, patients should inform their healthcare provider of any pre-existing medical conditions, particularly cardiovascular issues, hypertension, diabetes, or thyroid disorders. Special caution is warranted in elderly patients, as they may be more susceptible to the side effects of the medication. Pregnant and breastfeeding women should consult their healthcare provider before using ISTAVEL D, as the safety of its use in these populations has not been fully established.

Clinical Studies

Clinical studies evaluating the efficacy and safety of ISTAVEL D have demonstrated its effectiveness in managing symptoms of allergic rhinitis. In randomized controlled trials, patients reported significant improvements in nasal congestion, sneezing, and overall quality of life compared to placebo groups. The combination of an antihistamine and a decongestant has been shown to provide superior relief of symptoms compared to either component alone. Long-term studies have indicated that ISTAVEL D is well-tolerated, with a low incidence of serious side effects.

Conclusion

ISTAVEL D 5/50 MG is a valuable therapeutic option for individuals suffering from allergic conditions. Its dual-action formulation effectively addresses both nasal and ocular symptoms, providing comprehensive relief. While generally well-tolerated, it is essential for patients to use ISTAVEL D responsibly and under the guidance of a healthcare provider. Awareness of potential side effects, contraindications, and drug interactions will help ensure safe and effective use of this medication.